Chinese Startups, US Biotechs Price IPOs Raising $121M
Two Chinese startups, a U.S. medical device company and a brain-cancer focused biotechnology company raised a combined $121 million in initial public offerings that began trading Friday, as what had been...To view the full article, register now.
Already a subscriber? Click here to view full article